David, one of the original founders of the Company, is a leader in the field of structure based drug design. Following doctoral studies in chemistry at the University at Buffalo, he spent ten years at Merck Sharp and Dohme Research Laboratories, where he directed a variety of drug discovery projects. In 1989, he returned to…
Dr. Barnett is a successful drug development executive who brought four drugs, two of which are blockbusters, to the marketplace during his tenure at Schering-Plough (SP). He led the effort that resulted in the discovery of Claritin (and Clarinex), a non-sedating antihistamine that is Schering-Plough’s leading product and was the fifth leading drug, based on…
